KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,139 | -24.6% | 84,432 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $150,007 | -89.0% | 83,803 | -10.6% | 0.00% | -95.0% |
| Q3 2020 | $1,368,000 | -27.6% | 93,706 | -6.1% | 0.02% | -20.0% |
| Q2 2020 | $1,889,000 | +427.7% | 99,749 | +148.2% | 0.02% | +525.0% |
| Q1 2016 | $358,000 | -42.6% | 40,184 | -14.6% | 0.00% | -33.3% |
| Q4 2015 | $624,000 | -89.4% | 47,071 | -15.7% | 0.01% | 0.0% |
| Q3 2015 | $5,883,000 | +510.3% | 55,870 | +57.7% | 0.01% | -25.0% |
| Q2 2015 | $964,000 | +77.9% | 35,431 | +100.1% | 0.01% | +100.0% |
| Q1 2015 | $542,000 | – | 17,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |